Claire M Phibbs1, Katy B Kozhimannil2, Stephanie A Leonard3, Scott A Lorch4, Elliott K Main3, Susan K Schmitt5, Ciaran S Phibbs6. 1. Loyola Marymount University, Los Angeles, California. 2. Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, Minnesota. 3. Department of Obstetrics & Gynecology, Stanford University School of Medicine, Palo Alto, California; California Maternal Quality Care Collaborative, Palo Alto, California. 4. Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Leonard Davis Institute of Health Economics, Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania. 5. Health Economics Resource Center, Veterans Affairs Palo Alto Healthcare System, Menlo Park, California; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California. 6. Health Economics Resource Center, Veterans Affairs Palo Alto Healthcare System, Menlo Park, California; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California. Electronic address: cphibbs@stanford.edu.
Abstract
INTRODUCTION: The objectives of this study were to include readmissions and physician costs in the estimates of total costs of severe maternal morbidity (SMM), to consider the effect of SMM on maternal length of stay (LOS), and to examine these for the more restricted definition of SMM that excludes transfusion-only cases. METHODS: California linked birth certificate-patient discharge data for 2009 through 2011 (n = 1,262,862) with complete costs and LOS were used in a secondary data analysis. Cost-to-charge ratios were used to estimate costs from charges, adjusting for inflation. Physician payments were estimated from the mean payments for specific diagnosis-related groups. Generalized linear models estimated the association between SMM and costs and LOS. RESULTS: Excluding readmissions and physician costs, SMM was associated with a 60% increase in hospital costs (marginal effect [ME] $3,550) and a 33% increase in LOS (ME 0.9 days). These increased to 70% (ME $5,806) and 46% (ME 1.3 days) when physician costs and readmissions were included. The effects of SMM were roughly one-half as large for patients who only required a blood transfusion (49% [ME $4,056] and 31% [ME 0.9 days]) as for patients who had another indicator for SMM (93% [ME $7,664] and 62% [ME 1.7 days]). CONCLUSIONS: Postpartum hospital readmissions and physician costs are important and previously unreported contributors to the costs of SMM. Excess costs and LOS associated with SMM vary considerably by indication. Cost effects were larger than the LOS effects, indicating that SMM increases treatment intensity beyond increasing LOS, and decreasing SMM may have broader health and cost benefits than previously understood. Published by Elsevier Inc.
INTRODUCTION: The objectives of this study were to include readmissions and physician costs in the estimates of total costs of severe maternal morbidity (SMM), to consider the effect of SMM on maternal length of stay (LOS), and to examine these for the more restricted definition of SMM that excludes transfusion-only cases. METHODS: California linked birth certificate-patient discharge data for 2009 through 2011 (n = 1,262,862) with complete costs and LOS were used in a secondary data analysis. Cost-to-charge ratios were used to estimate costs from charges, adjusting for inflation. Physician payments were estimated from the mean payments for specific diagnosis-related groups. Generalized linear models estimated the association between SMM and costs and LOS. RESULTS: Excluding readmissions and physician costs, SMM was associated with a 60% increase in hospital costs (marginal effect [ME] $3,550) and a 33% increase in LOS (ME 0.9 days). These increased to 70% (ME $5,806) and 46% (ME 1.3 days) when physician costs and readmissions were included. The effects of SMM were roughly one-half as large for patients who only required a blood transfusion (49% [ME $4,056] and 31% [ME 0.9 days]) as for patients who had another indicator for SMM (93% [ME $7,664] and 62% [ME 1.7 days]). CONCLUSIONS: Postpartum hospital readmissions and physician costs are important and previously unreported contributors to the costs of SMM. Excess costs and LOS associated with SMM vary considerably by indication. Cost effects were larger than the LOS effects, indicating that SMM increases treatment intensity beyond increasing LOS, and decreasing SMM may have broader health and cost benefits than previously understood. Published by Elsevier Inc.
Authors: Renata E Howland; Meghan Angley; Sang Hee Won; Wendy Wilcox; Hannah Searing; Sze Yan Liu; Emily White Johansson Journal: Matern Child Health J Date: 2019-03
Authors: Anna I Girsen; Lillian Sie; Suzan L Carmichael; Henry C Lee; Megan E Foeller; Maurice L Druzin; Ronald S Gibbs Journal: J Perinatol Date: 2019-08-28 Impact factor: 2.521
Authors: Joanna H Tu; Jochen Profit; Kathryn Melsop; Taylor Brown; Alexis Davis; Elliot Main; Henry C Lee Journal: Am J Perinatol Date: 2016-08-03 Impact factor: 1.862
Authors: Brian T Bateman; Jill M Mhyre; Sonia Hernandez-Diaz; Krista F Huybrechts; Michael A Fischer; Andreea A Creanga; William M Callaghan; Joshua J Gagne Journal: Obstet Gynecol Date: 2013-11 Impact factor: 7.661
Authors: Claire M Phibbs; Katy B Kozhimannil; Stephanie A Leonard; Scott A Lorch; Elliott K Main; Susan K Schmitt; Ciaran S Phibbs Journal: J Perinatol Date: 2022-02-18 Impact factor: 3.225